Glaukos (NYSE:GKOS) Sets New 52-Week High - Time to Buy?

Glaukos (NYSE:GKOS) Sets New 52-Week High - Time to Buy?

Glaukos (NYSE:GKOS) Hits New 52-Week High - Here's What Happened

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings Signal Promising Upside in the Medical Device Arena

Glaukos Corporation (NYSE: GKOS), a pioneering force in the healthcare sector, particularly within the medical devices industry, is catching the attention of investors with its innovative approach to ophthalmic treatments. With a market capitalization of $8.46 billion, Glaukos has carved a niche in developing therapies for glaucoma, corneal disorders, and retinal diseases. The company’s stock is currently priced at $144.01, marking the upper end…